<DOC>
	<DOCNO>NCT01828775</DOCNO>
	<brief_summary>This pilot randomize clinical trial study palliative care intervention improve quality life , psychological distress , communication patient solid tumor receive treatment phase I trials . Cancer patient experience many symptom related treatment cancer distress impact quality life . Palliative care focus manage symptom may help patient solid tumor live comfortably .</brief_summary>
	<brief_title>Palliative Care Intervention Improving Quality Life , Psychological Distress , Communication Patients With Solid Tumors Receiving Treatment</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Test effect palliative care intervention ( PCI ) patient ' quality life ( QOL ) , psychological distress satisfaction communication , compare experimental versus control group . II . Test effect PCI patient ' symptom intensity symptom interference daily activity , compare experimental versus control group . III . Test effect PCI patient ' hospital palliative care resource utilization clinical trial retention rate , compare experimental versus control group . IV . Test effect time PCI initiation ( early versus delay ) patient outcome , compare experimental versus control group . V. Describe patient ' satisfaction PCI . OUTLINE : Patients randomize 1 2 arm . ARM I : Patients receive part I PCI comprise quantitative survey , comprehensive palliative care assessment Research Nurses , goal care discussion begin prior administration first dose phase I treatment . Patients receive part II PCI comprise recommendation interdisciplinary team , patient educational session , supportive care referral follow first dose phase I treatment complete within one month first treatment . ARM II : Patients receive usual care 12 week post-treatment initiation . Patients receive part I II PCI . After completion study , patient follow 5 year .</detailed_description>
	<criteria>Patients diagnose solid tumor eligible participation Phase I clinical trial investigational cancer therapy Patients sign informed consent participation Phase I clinical trial Able read understand Englishthis include intervention study material ( include outcome measure ) English Ability read and/or understand study protocol requirement , provide write informed consent Patients diagnose hematologic ( population distinct solid tumor different trial ) cancer .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>